COVID-19 Resources
Learn about our commitment to supporting COVID-19 efforts.
COVID-19 and the Critically Ill Patient
- COVID-19 manifests primarily as an acute respiratory illness with interstitial and alveolar pneumonia, but it can affect multiple organs such as the kidney.1
- Early reports suggested a lower incidence (3%–9%) of AKI in those with COVID-19 infection compared to SARS and MERS-CoV infections. However, more recent information shows a higher frequency of renal dysfunction in hospitalized patients, with 15% having elevations in serum creatinine, an indicator of abnormal kidney function.2
- Critically ill patients with COVID-19 infection may present a higher incidence of AKI compared with less sick patients.3
- Whether AKI associated with COVID-19 infection is caused by a coronavirus-induced cytopathic effect or cytokine storm-induced systemic inflammatory response remains unclear.4
- The development of AKI in patients with COVID-19 infection has been associated with an increased risk of in-hospital mortality.5
Baxter's mission is to Save and Sustain Lives, and that commitment guides everything we do – even when the obstacles seem greatest. The heroic work by healthcare providers and first responders to care for those with COVID-19 inspires us all. We are committed to doing everything we can to support the healthcare system, our employees and our communities during this unprecedented time.
José (Joe) E. Almeida, chairman and chief executive officer
ESICM
European Society of Intensive Care Medicine
ASN
American Society of Nephrology
